Exploration of Prunus armeniaca Metabolites' Inhibitory Role in Colon Cancer: An In-silico Study
RADS Journal of Food Biosciences · 30.12.2025 · 4 (2) · 71-81
DOI: 10.37962/jfbs.v4i2.113 ↗Kurz gefasst
Fachartikel in der Zeitschrift RADS Journal of Food Biosciences, online erschienen am 30.12.2025. Verfasst von Alina Jahangeer und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Colon cancer, defined by the uncontrolled growth of cells in the colon, often begins with adenomatous polyps and is moderated by a combination of genetic, epigenetic, and environmental factors, including inflammation and oxidative stress. Due to increasing global prevalence, especially in developing countries, there is a need to develop effective prevention and treatment strategies against colon cancer. This study investigates the anticancer activity of Prunus Armeniaca metabolites against colon cancer using the in-silico method. Ten metabolites were studied, with special emphasis placed on their interaction with cancer-related proteins such as carbonic anhydrase IX, aldose reductase, and estrogen receptor beta. The 3D structures of the target proteins and ligands were used as inputs. The best ligand was chosen according to drug likeness, ADMET, and docking score. The study shows that hyperoside, with its good ADMET profile, is a good drug candidate. The docking score of hyperoside is stable with aldose reductase, -10.5 kJ/mol. To check the further effectiveness of hyperoside, it has been compared with a commercially available anti-cancer drug, i.e., fluorouracil. When a comparison of all drug-like properties has been carried out, it has been seen that hyperoside is comparable to fluorouracil in terms of ADMET results, but the docking score of hyperoside is much better than that of fluorouracil. Hence, it is concluded that hyperoside can prove itself as an anti-cancer drug in future therapeutics related to colon cancer.
Zitieren
APA
Jahangeer, A., Fatima, M., & Anwar, M. A. (2025). Exploration of Prunus armeniaca Metabolites' Inhibitory Role in Colon Cancer: An In-silico Study. RADS Journal of Food Biosciences, 4(2), 71-81. https://doi.org/10.37962/jfbs.v4i2.113
Vancouver
Jahangeer A, Fatima M, Anwar MA. Exploration of Prunus armeniaca Metabolites' Inhibitory Role in Colon Cancer: An In-silico Study. RADS Journal of Food Biosciences. 2025;4(2):71-81. doi:10.37962/jfbs.v4i2.113
BibTeX
@article{Jahangeer2025,
author = {Jahangeer, Alina and Fatima, Maliha and Anwar, Muhammad Asad},
title = {Exploration of Prunus armeniaca Metabolites' Inhibitory Role in Colon Cancer: An In-silico Study},
journal = {RADS Journal of Food Biosciences},
year = {2025},
volume = {4},
number = {2},
pages = {71--81},
doi = {10.37962/jfbs.v4i2.113}
}
EUVIMED